Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.

Author: AveryG S, BrogdenR N, PinderR M, SpeightT M

Paper Details 
Original Abstract of the Article :
Fenoprofen1 (dl-2-[3-phenoxyphenyl]propionic acid) is a new non-steroidal anti-inflammatory, antipyretic, analgesic agent advocated for use in rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis and gout. Published data suggest that in rheumatoid arthritis, fenoprofen 2.4 g dail...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/00003495-197713040-00001

データ提供:米国国立医学図書館(NLM)

Fenoprofen: A New Camel in the Desert of Rheumatic Disease Treatment

The quest for effective treatments for rheumatic diseases is a constant journey, much like navigating the vast and often unforgiving desert of pain and inflammation. This research focuses on fenoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its potential role in managing rheumatic conditions. It's like discovering a new, more resilient species of camel that can navigate the harsh terrain of these debilitating diseases.

The study highlights the efficacy of fenoprofen in treating rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis, and gout. The authors emphasize the potential of fenoprofen as a safe and effective treatment option, particularly when compared to other NSAIDs like aspirin and naproxen. It's like finding a new oasis in the desert of rheumatic disease treatment, offering a potentially more comfortable and effective way to manage the symptoms of these conditions.

Fenoprofen: A Valuable Oasis in the Desert of Rheumatic Disease Management

The study's findings suggest that fenoprofen may offer a valuable addition to the treatment arsenal for rheumatic diseases, providing an alternative option for patients who may not tolerate other NSAIDs. It's like finding a new, more accessible source of water in the desert, offering relief from the harsh conditions of pain and inflammation.

Navigating the Desert of Rheumatic Diseases: A Multifaceted Approach

While fenoprofen shows promise, it's important to remember that it's just one piece of the puzzle in the complex landscape of rheumatic disease management. It's like navigating a vast desert – one must utilize all the resources available and approach each challenge with a multifaceted strategy. Further research is needed to fully understand the long-term benefits and potential drawbacks of fenoprofen, ensuring that we're always navigating toward the best possible outcomes for patients.

Dr. Camel's Conclusion

This research introduces us to fenoprofen, a new camel in the desert of rheumatic disease treatment. It offers a potentially more comfortable and effective way to manage the symptoms of these conditions, providing hope for a brighter future for those affected. It's a journey of discovery, as we continue to seek new and innovative ways to combat the challenges of rheumatic diseases.

Date :
  1. Date Completed 1977-07-23
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

324748

DOI: Digital Object Identifier

10.2165/00003495-197713040-00001

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.